Eli Lilly $3B Wisconsin Plant Expansion Completed by End of 2026?
Yes • 50%
No • 50%
Eli Lilly's official press releases or financial reports
Eli Lilly Boosts Wisconsin Plant with $3B Investment, Adding 750 Jobs
Dec 5, 2024, 08:33 PM
Eli Lilly and Co. has announced a significant investment of $3 billion to expand its manufacturing facility in Pleasant Prairie, Wisconsin. The expansion aims to increase production capacity for diabetes and obesity medicines, responding to the soaring demand for these treatments. This move is part of a broader $23 billion investment in global manufacturing since 2020. The expansion is expected to create 750 new jobs and will benefit millions of patients globally by enhancing the supply of Lilly's weight-loss and diabetes drugs.
View original story
No • 50%
Yes • 50%
More than $1 billion • 25%
Less than $250 million • 25%
$250 million to $500 million • 25%
$500 million to $1 billion • 25%
Other • 25%
Novo Nordisk • 25%
Pfizer • 25%
Johnson & Johnson • 25%
No • 50%
Yes • 50%
More than $35 billion • 25%
Less than $25 billion • 25%
$25 billion to $30 billion • 25%
$30 billion to $35 billion • 25%
Improved Supply Chain Efficiency • 25%
Other • 25%
Job Creation • 25%
Increased Production Capacity • 25%